PAHC
Phibro Animal Health Corporation Healthcare - Drug Manufacturers - Specialty & Generic Investor Relations →
Phibro Animal Health Corporation (PAHC) closed at $54.89 as of 2026-05-01, trading 153.9% above its 200-week moving average of $21.62. The stock is currently moving closer to the line, down from 157.3% last week. With a 14-week RSI of 72, PAHC is in overbought territory.
Trading volume is running at 1.4x of its 14-week average, which is in the normal range. The balance between buying and selling volume (1.02 ratio) is neutral — neither side is clearly dominating.
Over the past 581 weeks of data, PAHC has crossed below its 200-week moving average 6 times. On average, these episodes lasted 52 weeks. Historically, investors who bought PAHC at the start of these episodes saw an average one-year return of +1.6%.
With a market cap of $2.2 billion, PAHC is a mid-cap stock. The company generates a free cash flow yield of 1.0%. Return on equity stands at 31.8%, indicating strong profitability. The stock trades at 6.7x book value.
Over the past 11.2 years, a hypothetical investment of $100 in PAHC would have grown to $203, compared to $420 for the S&P 500. PAHC has returned 6.5% annualized vs 13.7% for the index, underperforming the broader market over this period.
Free cash flow has been declining. A deteriorating cash flow trend warrants extra scrutiny — the stock may be cheap for a reason.
Business Health
Annual financials — how the underlying business has performed over the past several years.
Cash Flow Free cash flow & net income ($M)
Revenue Annual revenue ($M) — business growth proxy
Total Debt Balance sheet debt ($M)
ROIC Return on invested capital (%)
FCF Yield Free cash flow / market cap (%) — Yartseva signal
Gross Margin Pricing power & competitive moat (%)
Shares Outstanding Buybacks vs dilution (millions)
Growth of $100: PAHC vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After PAHC Crosses Below the Line?
Across 6 historical episodes, buying PAHC when it crossed below its 200-week moving average produced an average return of +3.3% after 12 months (median +8.0%), compared to +17.3% for the S&P 500 over the same periods. 50% of those episodes were profitable after one year. After 24 months, the average return was +10.7% vs +38.2% for the index.
Each line shows $100 invested at the moment PAHC crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Historical Touches
PAHC has crossed below its 200-week MA 6 times with an average 1-year return of +1.6% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| Feb 2016 | Sep 2016 | 32 | 35.0% | +9.7% | +139.9% |
| Oct 2016 | Nov 2016 | 5 | 6.5% | +43.0% | +152.4% |
| Nov 2016 | Dec 2016 | 1 | 1.1% | +28.0% | +150.7% |
| Dec 2018 | Mar 2019 | 14 | 11.8% | -21.0% | +106.3% |
| May 2019 | Jun 2021 | 109 | 46.6% | -22.9% | +117.4% |
| Jun 2021 | Apr 2024 | 149 | 47.5% | -27.0% | +118.0% |
| Average | 52 | — | +1.6% | — |
Frequently Asked Questions
Is PAHC below its 200-week moving average?
No. Phibro Animal Health Corporation (PAHC) is currently 153.9% above its 200-week moving average of $21.62. It would need to fall to $21.62 to cross below the line.
What is PAHC's 200-week moving average price?
Phibro Animal Health Corporation's 200-week moving average is $21.62 as of 2026-05-01. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.
What happens when PAHC drops below its 200-week moving average?
PAHC has crossed below its 200-week moving average 6 times in our data. On average, buying at that moment produced a one-year return of +1.6%. These dips have historically been decent entry points. These episodes lasted 52 weeks on average.
Is PAHC a good value right now?
Here's what our data says about PAHC as of 2026-05-01: The stock is above its 200-week moving average, so it doesn't currently meet our primary signal. The 14-week RSI is 72 (overbought). Free cash flow yield is 1.0%. Return on equity is 31.8%. Price-to-book is 6.7x. This is not a buy or sell recommendation — always do your own research.
How does PAHC compare to the S&P 500?
Over the past 11.2 years, $100 invested in PAHC would have grown to $203, compared to $420 for the S&P 500. That's 6.5% annualized vs 13.7% for the index. PAHC has underperformed the broader market over this period.
Does PAHC pay a dividend?
Yes. Phibro Animal Health Corporation currently pays a dividend yield of 87.00%.
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of week of 2026-05-01